Combination of aclarubicin and etoposide for the treatment of advanced acute myeloid leukemia: results of a prospective multicenter phase II trial. German AML Cooperative Group.

Source:http://linkedlifedata.com/resource/pubmed/id/9766494

Download in:

View as

General Info

PMID
9766494